Completed NA INTERVENTIONAL 1-arm NCT05375695

Feasibility of Time-Restricted Eating in the Treatment of Type 2 Diabetes (RESET2pilot)

Feasibility of Time-Restricted Eating in the Treatment of Type 2 Diabetes - the RESET2 Pilot Study

Sponsor: Hvidovre University Hospital

Updated 5 times since 2022 Last updated: Nov 16, 2022 Started: Apr 1, 2022 Primary completion: Nov 15, 2022 Completion: Nov 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Type 2 Diabetes, this trial is completed. The trial is conducted by Hvidovre University Hospital and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2022 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Nov 2022 — Dec 2022 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2022 — Nov 2022 [monthly]

Recruiting NA

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hvidovre University Hospital
Kristine Færch
Salk Institute for Biological Studies
University of Copenhagen
University of Leeds

Data source: Steno Diabetes Center Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Herlev, Denmark